The competitive situation of liver tissue engineering based on patent analysis

doi:10.3969/j.issn.2095-4344.2870

Abstract

Abstract:

BACKGROUND: China is a country with high incidence of liver disease. Liver tissue engineering, which is still in the stage of exploration, has brought a new hope for treatment.

OBJECTIVE: To provide advices and references for the development and innovation of liver tissue

engineering based on patent analysis.

METHODS: The number and development tendency, as well as the technology birthplace, target market, applicants, inventors and technical fields of patents in the field of liver tissue engineering in nearly 20 years were analyzed in this study. The keywords for full-text search included tissue engineering, tissue regenerate/repair, and hepatic/liver. The retrieval deadline was December 28, 2018.

RESULTS AND CONCLUSION: There is a rapid development in the field of the global liver tissue engineering. The compound growth rate in the past 10 years is 8.64%, of which invention patents account for 84.93%. China is the main technology birthplace; however, the number of tripartite patents of China is far less than that of the United States and Japan. China and the United States are the two most high-profile target markets in the field of liver tissue engineering, but the applicants are mostly from native instead of international. Meanwhile, there are 8 Chinese application institutions and 14 Chinese inventors ranking among the top 20 in the world in this field. In conclusion, liver tissue engineering has developed rapidly in China, but the lack of core technology is still an important issue. Therefore, we must improve our innovation capabilities and explore core technologies continuously to enhance our international competitiveness.

Key words: liver tissue engineering, competitive situation, patent, patent analysis, patentometrics, core technology

CLC Number:

Wang Tingting, Zhang Ting, Xu Dongzi, Ouyang Zhaolian. The competitive situation of liver tissue engineering based on patent analysis[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(32): 5192-5197.

Figures/Tables 10

References

[1] 邬迪,王志伟.脱细胞技术及其在肝脏组织工程中的应用[J].江苏医药,2014,40(18):2176-2179.

[2] 游辅宇,高毅.生物三维打印技术在肝组织工程的应用与展望[J].重庆医学,2018,47(31):4056-4058.

[3] 曾敏,傅恭博,鄢和新.基于脱细胞技术的肝脏组织工程研究进展[J].肝脏,2017,22(2):165-167.

[4] 刘鹏,向俊西,郑幸龙,等.基于脾脏脱细胞支架构建组织工程肝脏的体内植入策略[J].南方医科大学学报,2018,38(6):698-703.

[5] 王鑫英,周伦,陈亚慧.人造肝脏研究进展[J].器官移植,2017,8(6): 480-482.

[6] 杨扬,王励.肝脏组织工程研究进展[J].器官移植,2017,8(5): 337-343.

[7] 胡泉,李颖,周瑾,等.肝组织工程的研究进展与展望[J].生物医学工程研究,2009,28(1):79-82.

[8] 张婷,池慧,欧阳昭连.基于专利分析的手术机器人竞争态势研究[J].中国医学装备,2018,15(7):119-123.

[9] 林鑫,肖宇锋,张佳维,等.基于专利计量分析的国际抗高血压药物研究[J].中国新药杂志,2019,28(15):1797-1802.

[10] 房梦雅,王青华,徐来,等.基于德温特专利数据库近10年组织工程支架､技术､假体领域的专利分析[J].中国组织工程研究,2019, 23(18):2894-2899.

[11] 陈娟,武一丹,张婷,等.中国组程织工基础研究实力:基于文献计量学的分析[J].中国组织工程研究,2019,23(26):4175-4180.

[12] 张婷,陈娟,欧阳昭连,等.组织工程与再生医学领域的专利竞争态势[J].中国组织工程研究,2019,23(34):5479-5485.

[13] 张婷,陈娟,池慧,等.基于专利分析的医疗器械领域技术竞争态势研究[J].中国医疗设备,2019,34(5):107-113.

[14] 汪庆,李军莲,朱钦磊,等.基于专利分析的基因组编辑技术国际竞争态势研究分析[J].中华医学图书情报杂志,2019,28(2):12-18.

[15] 石亮,张善杰,刘晓琴.专利视角下的全球深海采矿技术发展态势分析与对策建议[J].情报探索,2019,(4):41-51.

[16] CHUN HJ, PARK CH, KWON IK, et al. Cutting-Edge Enabling Technologies for Regenerative Medicine. Singapore: Springer. 2018.

[17] WANG X, AO Q, TIAN X, et al. Gelatin-Based Hydrogels for Organ 3D Bioprinting. Polymers. 2017;9(12):401.

[18] WANG X, LIU C. Fibrin Hydrogels for Endothelialized Liver Tissue Engineering with a Predesigned Vascular Network. Polymers. 2018;10(10):1048.

[19] WANG X, YAN Y, PAN Y, et al. Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng. 2006;12(1):83-90.

[20] ZHOU Q, LI L, LI J. Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications. Liver Int. 2015;35(3):687-694.

[21] HU C, LI L. In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases. Stem Cells Int. 2015; 2015:1-11.

[22] WANG LY, LIU LP, GE JY, et al. A Multiple-Cell Microenvironment in a 3-Dimensional System Enhances Direct Cellular Reprogramming Into Hepatic Organoids. Transplant Proc. 2018;50(9):2864-2867.

[23] FOX DB, COOK JL, ARNOCZKY SP, et al. Fibrochondrogenesis of free intraarticular small intestinal submucosa scaffolds. Tissue eng. 2004;10(1-2):129-137.

[24] AGARWAL T, SUBRAMANIAN B, MAITI TK. Liver Tissue Engineering: Challenges and Opportunities. ACS Biomater Sci Eng. 2019;5(9):4167-4182.

[25] RODRÍGUEZ-SALVADOR M, RIO-BELVER RM, GARECHANA-ANACABE G. Scientometric and patentometric analyses to determine the knowledge landscape in innovative technologies: the case of 3D bioprinting. PLoS One. 2017; 12(6):e180375.

[26] 罗涛.基于3D打印技术构建类肝组织及体内外活性分析[D].杭州:浙江省医学科学院,2018.

[27] LI J, XING F, CHEN F, et al. Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages. Cell Transplant. 2019;28(5):510-521.

[28] ZHANG L, GUAN Z, YE J, et al. Research progress in liver tissue engineering. Biomed Mater Eng. 2017;28(s1): S113-S119.

[29] 丁宇峰.中美专利质量控制措施比较与启示[J].理论与改革, 2016,(4):160-165.

[30] 何甜田.中国专利质量问题研究[D].济南:山东大学,2014.